Actively Recruiting
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
Led by University of California, San Francisco · Updated on 2026-01-08
200
Participants Needed
2
Research Sites
376 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
V
Vanderbilt University Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.
CONDITIONS
Official Title
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 years or older with a diagnosis of sarcoidosis
- Diagnosis confirmed by tissue biopsy following the 1999 American Thoracic Society criteria
- Exclusion of other conditions like beryllium sensitization, chronic beryllium disease, mycobacterial, viral, or fungal infections
You will not qualify if you...
- Unable to tolerate study procedures as judged by the investigator
- Pregnant or breastfeeding
- Having other medical diagnoses that affect biomarker expression, such as common variable immunodeficiency, HIV infection, or autoimmune diseases
- Having other interstitial lung diseases like hypersensitivity pneumonitis or idiopathic pulmonary fibrosis
- Hematocrit (Packed Cell Volume) less than 25%
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University of Maryland
Baltimore, Maryland, United States, 21201
Actively Recruiting
2
UT Southwestern
Dallas, Texas, United States, 75390
Actively Recruiting
Research Team
L
Laura Koth
CONTACT
J
Jessica Cardenas
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here